|
|
|
MIRA INFORM REPORT
|
Report No. : |
516703 |
|
Report Date : |
25.06.2018 |
IDENTIFICATION DETAILS
|
Name : |
MACLEODS
PHARMACEUTICALS LIMITED |
|
|
|
|
Formerly Known
As : |
MACLEODS
PHARMACEUTICALS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
304-307, 3rd
Floor, Atlanta Arcade, Marol Church Road, Andheri (East), Mumbai – 400059,
Maharashtra |
|
Tel. No.: |
91-22-67695800 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of Incorporation
: |
05.06.1989 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 199.607
Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239MH1989PLC052049 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
0391172867 |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
27AAACM4100C1Z9 |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACM4100C |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of Pharmaceuticals Products such as Drug,
Medicines and Allied Products.
[Registered Activity] |
|
|
|
|
No. of Employees
: |
Information denied by the management |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January
2017)
|
MIRA’s Rating : |
A++ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
Maximum Credit Limit : |
USD 106800000 |
|
|
|
|
Status : |
Excellent |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Exists |
|
|
|
|
Comments : |
Macleods Pharmaceuticals Limited is engaged in manufacturing of
pharmaceutical products. The company was incorporated in the year 1989 and is
based in Mumbai, Maharashtra. It is an established company having excellent
track record. For the financial year ended 2017, the company has witnessed a growth
in its revenue and has achieved decent profit margin at 18.67%
(approximately). The company possesses strong financial profile marked by healthy net
worth position along with negligible debt recorded. The company also derives strength from its long established track
record of business operation backed by extensive experience of its promoters. Fundamentals of the company are healthy. Trade relations are reported as fair. Business is active. Payments
terms are seems to be regular and as commitment. In view of long track record and strong financial base, the company
can be considered good for normal business dealings at usual trade terms and
conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (31.12.2017) |
Current Rating (01.04.2018) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2018.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 25.06.2018.
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DENIED
MANAGEMENT NON-COOPERATIVE (Tel. No.:
91-22-66762800)
LOCATIONS
|
Registered Office/ Factory 1 : |
304-307, 3rd
Floor, Atlanta Arcade, Marol Church Road, Andheri (East), Mumbai – 400059,
Maharashtra, India |
|
Tel. No.: |
91-22-66762800 |
|
Fax No.: |
91-22-29256599 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Corporate Office : |
501-503, A Wing, Everest Grande, Shanti Nagar, Mahakali Caves Road, Andheri (East), Mumbai-400093, Maharashtra, India |
|
|
|
|
Head Office: |
G-2, Saket Building, M.I.D.C. Shanti Nagar, Next to Onida House,
Mahakali Caves Road, Andheri (East), Mumbai – 400093, Maharashtra, India |
|
Tel No.: |
91-22-28314611 |
|
|
|
|
Factory 2 : |
Village: Theda, Kharuni- Lodimajra, Thehesil- Nalagarh, Baddi Industrial Estate Area, District Solan, Himachal Pradesh, India |
|
|
|
|
Factory 3 / Daman- Premier-Unit II : |
Plot No. 25-27, Survey No. 366, Premier Industrial Estate, Kachigam, Daman – 396 320, Daman and Diu (U.T.), India |
|
|
|
|
Factory 4 : |
Plot No.2209, GIDC Sarigam, Ta. Umargam, District Valsad, Gujarat, India |
DIRECTORS
AS ON 31.03.2017
|
Name : |
Mr. Banwarilal Murildhar Bawri |
|
Designation : |
Managing Director |
|
Address : |
5, Vinayak Heights, Upper Govind Nagar, Malad (East), Mumbai – 400097, Maharashtra, India |
|
Date of Birth/Age : |
02.04.1953 |
|
Qualification : |
D. Pharm |
|
Date of Appointment : |
01.04.2010 |
|
PAN No.: |
AAKPB1114E |
|
DIN No.: |
00017795 |
|
|
|
|
Name : |
Dr. Rajendra Murlidhar Agarwal |
|
Designation : |
Managing Director |
|
Address : |
5, Vinayak Heights, Upper Govind Nagar, Malad (East), Mumbai – 400097, Maharashtra, India |
|
Date of Birth/Age : |
25.02.1959 |
|
Qualification : |
M.B.B.S. |
|
Date of Appointment : |
01.04.2010 |
|
PAN No.: |
AABPA9611N |
|
DIN No.: |
00034224 |
|
|
|
|
Name : |
Mr. Girdharilal Murlidhar Bawri |
|
Designation : |
Director |
|
Address : |
5, Vinayak Heights, Upper Govind Nagar, Malad (East), Mumbai – 400097, Maharashtra, India |
|
Date of Birth/Age : |
03.08.1947 |
|
Qualification : |
B. Com / D. Pharma |
|
Date of Appointment : |
22.05.1990 |
|
PAN No.: |
AABPB7048L |
|
DIN No.: |
00034197 |
|
|
|
|
Name : |
Dr. Ruchi Rajendra Agarwal |
|
Designation : |
Director |
|
Address : |
5/6 Vinayak Heights, Upper Govind Nagar, Malad (East), Mumbai - 400097, Maharashtra, India |
|
Date of Birth/Age : |
22.08.1992 |
|
Date of Appointment : |
30.03.2015 |
|
DIN No.: |
07139918 |
|
|
|
|
Name : |
Mr. Mihir Bipin Shah |
|
Designation : |
Director |
|
Address : |
B/105, Building No.30, Near ICICI Bank Tilak Nagar, Chembur, Mumbai - 400089, India |
|
Date of Birth/Age : |
12.01.1983 |
|
Date of Appointment : |
01.07.2016 |
|
DIN No.: |
07586469 |
|
|
|
|
Name : |
Dr. Ashok Anant Mahashur |
|
Designation : |
Director |
|
Address : |
A 509, Dhanvantari CHS, Deonar Municipal Colony, Sector 2, Deonar, Mumbai - 400043, Maharashtra, India |
|
Date of Birth/Age : |
14.12.1948 |
|
Date of Appointment : |
30.03.2015 |
|
DIN No.: |
07158239 |
KEY EXECUTIVES
|
Name : |
Mrs. Suvarna Dadabhau Gholap |
|
Designation : |
Company Secretary |
|
Address : |
103-A, Building No.26, Tilak Nagar, Chembur, Mumbai – 400089, Maharashtra,
India |
|
Date of Birth/Age : |
15.07.1982 |
|
Date of Appointment : |
01.03.2011 |
|
PAN No.: |
ANJPG7538B |
|
|
|
|
Name : |
Mr. Vinayak Vasudev Shirodkar |
|
Designation : |
Chief Finance Officer |
|
Address : |
B 401, Windsor, Shiv Vallabh Road, Borivali (East), Mumbai - 400066, Maharashtra, India |
|
Date of Appointment : |
01.10.2014 |
|
PAN No.: |
AAFPS7254R |
MAJOR SHAREHOLDERS
AS ON 29.09.2017
|
Names of Shareholders |
|
No. of Shares |
|
Banwarilal Bawri |
|
3022080 |
|
Ajay Agarwal |
|
2172550 |
|
Anju Agarwal |
|
3256200 |
|
Rajendra Agarwal |
|
3084360 |
|
Girdharilal Bawri |
|
2235360 |
|
Sudha Bawri |
|
884080 |
|
Anushree Agarwal |
|
229200 |
|
Ruchi Agarwal |
|
192840 |
|
Taradevi Bawri |
|
162000 |
|
Rajendra Agarwal HUF |
|
120000 |
|
Vijay Agarwal |
|
2083610 |
|
Prateek Agarwal |
|
2518400 |
|
Total |
|
19960680 |
AS ON 29.09.2017
|
Equity Share
Break up |
Percentage |
|
Category |
|
|
Promoters - Individual/Hindu Undivided Family – Indian |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Pharmaceuticals Products such as Drug,
Medicines and Allied Products.
[Registered Activity] |
||||
|
|
|
||||
|
Products / Services
: |
|
||||
|
|
|
||||
|
Brand Names : |
Not Available |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
Not Divulged |
||||
|
|
|
||||
|
Imports : |
Not Divulged |
||||
|
|
|
||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS – (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Information denied by the management |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
|
|
Auditors : |
|
|
Name : |
Bansal Bansal and Company Chartered Accountants |
|
Address : |
120, Building No.6, Mittal Industrial Estate,
Mumbai 400059, Maharashtra, India |
|
Income-tax
PAN of auditor or auditor's firm : |
AABFB5224E |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Associate Company: |
Macleods Social Welfare Foundation CIN No.: U85100MH2015NPL264873 |
|
|
|
|
Joint Venture: |
Pharmaceutical Institute Macleods (Morocco) |
|
|
|
|
Subsidiary
Companies : |
· East and West Clothing Private Limited, India CIN No.:U29140MH1975PTC018072 · Macleods Pharma UK Limited · Macleods Pharmaceuticals SA (PTY) Limited · Macleods Pharmaceuticals Limited, Peru S.A.C. · Macleods Pharmaceuticals Limited, Ukraine · Macleods Pharma USA, INC · Macleods Pharma Japan · Macleods Pharma Espana SLU |
|
|
|
|
Enterprise under
Significant Influence of Key management Personnel or their relatives : |
· Oxalis Labs · Pharma Centre · Macleods Laboratories Private Limited CIN No.: U85195MH1987PTC045607 |
CAPITAL STRUCTURE
AS ON 29.09.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
25000000 |
Equity Shares |
INR 10/- each |
INR 250.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
19960680 |
Equity Shares |
INR 10/- each |
INR 199.607
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
INR Million]
ABRIDGED
BALANCE SHEET (STANDALONE)
|
SOURCES OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
199.607 |
199.607 |
199.607 |
|
(b) Reserves &
Surplus |
37177.397 |
27414.329 |
21672.374 |
|
(c) Money received
against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application
money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total Shareholders’ Funds
|
37377.004 |
27613.936 |
21871.981 |
|
|
|
|
|
|
(3) Non-Current
Liabilities |
|
|
|
|
(a) long-term borrowings |
76.850 |
76.850 |
19.508 |
|
(b) Deferred tax
liabilities (Net) |
693.837 |
491.325 |
324.534 |
|
(c) Other long term
liabilities |
384.789 |
165.338 |
132.313 |
|
(d) long-term provisions |
874.556 |
286.784 |
160.040 |
|
Total Non-current
Liabilities |
2030.032 |
1020.297 |
636.395 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
1166.120 |
1773.114 |
1486.073 |
|
(b) Trade payables |
6666.738 |
4989.174 |
3805.004 |
|
(c) Other current
liabilities |
2486.645 |
2304.123 |
1755.866 |
|
(d) Short-term provisions |
134.736 |
109.019 |
1.038 |
|
Total Current Liabilities
|
10454.239 |
9175.430 |
7047.981 |
|
|
|
|
|
|
TOTAL |
49861.275 |
37809.663 |
29556.357 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
10606.997 |
8757.360 |
5282.112 |
|
(ii) Intangible Assets |
33.977 |
31.770 |
34.981 |
|
(iii) Capital
work-in-progress |
145.858 |
1042.150 |
2019.998 |
|
(iv) Intangible assets
under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current
Investments |
12863.449 |
100.943 |
102.979 |
|
(c) Deferred tax assets
(net) |
1299.971 |
1121.212 |
0.000 |
|
(d) Long-term Loan and Advances |
240.699 |
266.048 |
1094.373 |
|
(e) Other Non-current
assets |
2357.491 |
4799.930 |
5575.527 |
|
Total Non-Current Assets |
27548.442 |
16119.413 |
14109.970 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
350.257 |
0.000 |
0.000 |
|
(b) Inventories |
7891.112 |
5924.859 |
4837.150 |
|
(c) Trade receivables |
6251.776 |
5644.746 |
3501.163 |
|
(d) Cash and cash
equivalents |
5856.103 |
7572.707 |
4761.183 |
|
(e) Short-term loans and
advances |
4.307 |
10.230 |
1417.769 |
|
(f) Other current assets |
1959.278 |
2537.708 |
929.122 |
|
Total Current Assets |
22312.833 |
21690.250 |
15446.387 |
|
|
|
|
|
|
TOTAL |
49861.275 |
37809.663 |
29556.357 |
PROFIT
& LOSS ACCOUNT (STANDALONE)
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SALES |
|
|
|
|
|
Income |
51344.423 |
40424.602 |
34690.095 |
|
|
Other Income |
1083.521 |
1179.568 |
907.029 |
|
|
TOTAL |
52427.944 |
41604.170 |
35597.124 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
15862.726 |
11900.590 |
11019.619 |
|
|
Purchases of
Stock-in-Trade |
6863.498 |
5592.675 |
5431.757 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
(1362.906) |
(220.066) |
(484.048) |
|
|
Employees benefits expense |
6444.569 |
5334.611 |
4258.744 |
|
|
Other expenses |
11680.147 |
10077.606 |
7989.872 |
|
|
TOTAL |
39488.034 |
32685.416 |
28215.944 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE
INTEREST, TAX, DEPRECIATION AND AMORTISATION |
12939.910 |
8918.754 |
7381.180 |
|
|
|
|
|
|
|
Less |
FINANCIAL EXPENSES |
56.664 |
77.514 |
34.716 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE
TAX, DEPRECIATION AND AMORTISATION |
12883.246 |
8841.240 |
7346.464 |
|
|
|
|
|
|
|
Less |
DEPRECIATION/
AMORTISATION |
700.748 |
526.175 |
406.898 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE TAX |
12182.498 |
8315.065 |
6939.566 |
|
|
|
|
|
|
|
Less |
TAX |
2598.258 |
1852.383 |
1483.322 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) AFTER TAX
|
9584.240 |
6462.682 |
5456.244 |
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
16940.717 |
9408.146 |
6619.409 |
|
|
Other earnings (Product
Development) |
176.696 |
151.818 |
146.436 |
|
|
TOTAL EARNINGS |
17117.413 |
9559.964 |
6765.845 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
480.16 |
323.77 |
273.35 |
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
Net cash flows from (used in) operations |
12790.938 |
6273.871 |
6670.450 |
|
Net cash flows from (used in) operating activities |
10189.444 |
4375.222 |
5174.888 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry
Debtors / Income * 365) |
44.44 |
50.97 |
36.84 |
|
|
|
|
|
|
Account Receivables Turnover (Income /
Sunday Debtors) |
8.21 |
7.16 |
9.91 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
107.07 |
104.10 |
84.42 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
1.64 |
1.51 |
1.53 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
1.20 |
0.91 |
1.01 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.21 |
0.24 |
0.24 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
0.03 |
0.07 |
0.07 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
0.28 |
0.33 |
0.32 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
0.29 |
0.36 |
0.34 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
228.36 |
115.06 |
212.62 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin [(PAT
/ Sales) * 100] |
% |
18.67 |
15.99 |
15.73 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
19.22 |
17.09 |
18.46 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
25.64 |
23.40 |
24.95 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current
Assets / Current Liabilities) |
2.13 |
2.36 |
2.19 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
1.38 |
1.72 |
1.51 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.75 |
0.73 |
0.74 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
6.23 |
9.27 |
7.54 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
2.13 |
2.36 |
2.19 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR In Million |
INR In Million |
INR In Million |
|
Share Capital |
199.607 |
199.607 |
199.607 |
|
Reserves & Surplus |
21672.374 |
27414.329 |
37177.397 |
|
Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Net worth |
21871.981 |
27613.936 |
37377.004 |
|
|
|
|
|
|
Long-term borrowings |
19.508 |
76.850 |
76.850 |
|
Short term borrowings |
1486.073 |
1773.114 |
1166.120 |
|
Total borrowings |
1505.581 |
1849.964 |
1242.970 |
|
Debt/Equity ratio |
0.069 |
0.067 |
0.033 |
YEAR-ON-YEAR GROWTH
|
Year on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR In Million |
INR In Million |
INR In Million |
|
Sales |
34690.095 |
40424.602 |
51344.423 |
|
|
|
16.531 |
27.013 |
NET PROFIT MARGIN
|
Net Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR In Million |
INR In Million |
INR In Million |
|
Sales |
34690.095 |
40424.602 |
51344.423 |
|
Profit |
5456.244 |
6462.682 |
9584.240 |
|
|
15.73% |
15.99% |
18.67% |
ABRIDGED
BALANCE SHEET (CONSOLIDATED)
|
SOURCES OF FUNDS |
|
31.03.2017 |
31.03.2016 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
|
199.607 |
199.607 |
|
(b) Reserves &
Surplus |
|
36628.789 |
27206.403 |
|
(c) Money received
against share warrants |
|
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
|
0.000 |
0.000 |
|
Total Shareholders’ Funds
(1) + (2) |
|
36828.396 |
27406.010 |
|
|
|
|
|
|
(3) Non-Current
Liabilities |
|
|
|
|
(a) long-term borrowings |
|
76.850 |
76.850 |
|
(b) Deferred tax
liabilities (Net) |
|
0.000 |
0.000 |
|
(c) Other long term
liabilities |
|
384.790 |
165.338 |
|
(d) long-term provisions |
|
878.852 |
290.816 |
|
Total Non-current
Liabilities (3) |
|
1340.492 |
533.004 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
|
0.000 |
0.000 |
|
(b) Trade payables |
|
7885.923 |
6014.557 |
|
(c) Other current
liabilities |
|
1925.948 |
2641.983 |
|
(d) Short-term provisions |
|
731.748 |
595.187 |
|
Total Current Liabilities
(4) |
|
10543.619 |
9251.727 |
|
|
|
|
|
|
TOTAL |
|
48712.507 |
37190.741 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
|
10644.173 |
8794.478 |
|
(ii) Intangible Assets |
|
117.360 |
146.720 |
|
(iii) Capital
work-in-progress |
|
145.858 |
1042.150 |
|
(iv) Intangible assets
under development |
|
0.000 |
0.000 |
|
(b) Non-current
Investments |
|
13131.910 |
19.160 |
|
(c) Deferred tax assets
(net) |
|
620.251 |
631.028 |
|
(d) Long-term Loan and Advances |
|
3.665 |
11.158 |
|
(e) Other Non-current
assets |
|
2506.398 |
4803.010 |
|
Total Non-Current Assets |
|
27169.615 |
15447.704 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
|
0.000 |
0.000 |
|
(b) Inventories |
|
8368.594 |
6095.884 |
|
(c) Trade receivables |
|
5292.240 |
5392.159 |
|
(d) Cash and cash
equivalents |
|
5975.976 |
7607.428 |
|
(e) Short-term loans and
advances |
|
4.307 |
10.230 |
|
(f) Other current assets |
|
1901.775 |
2637.336 |
|
Total Current Assets |
|
21542.892 |
21743.037 |
|
|
|
|
|
|
TOTAL |
|
48712.507 |
37190.741 |
PROFIT
& LOSS ACCOUNT (CONSOLIDATED)
|
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
|
|
SALES |
|
|
|
|
|
Income |
|
51491.645 |
40738.649 |
|
|
Other Income |
|
1059.376 |
1181.252 |
|
|
TOTAL |
|
52551.021 |
41919.901 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
|
15915.576 |
11935.966 |
|
|
Purchases of
Stock-in-Trade |
|
6958.301 |
5670.170 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
|
(1669.395) |
(192.095) |
|
|
Employees benefits
expense |
|
6579.987 |
5462.627 |
|
|
Exceptional items |
|
0.013 |
0.003 |
|
|
Other expenses |
|
12149.323 |
10273.839 |
|
|
TOTAL |
|
39933.805 |
33150.510 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE
INTEREST, TAX, DEPRECIATION AND AMORTISATION |
|
12617.216 |
8769.391 |
|
|
|
|
|
|
|
Less |
FINANCIAL EXPENSES |
|
56.664 |
79.850 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE
TAX, DEPRECIATION AND AMORTISATION |
|
12560.552 |
8689.541 |
|
|
|
|
|
|
|
Less |
DEPRECIATION/
AMORTISATION |
|
710.256 |
546.657 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE TAX |
|
11850.296 |
8142.884 |
|
|
|
|
|
|
|
Less |
TAX |
|
2586.343 |
1869.625 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) AFTER TAX
|
|
9263.953 |
6273.259 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
|
464.11 |
314.28 |
LEGAL
CASE
|
Case Details Bench:-Bombay
|
|||||||||||||||||||||||||||||||||||||||||||||||||
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
No |
|
8 |
Designation of contact person |
No |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners / Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
No |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
Yes |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
OVERVIEW-CORPORATE
INFORMATION:
The Company is a closely held Public Company domiciled in India and incorporated under the provisions of the Companies Act, 1956. The Company is engaged in the business of pharmaceutical and related activities, including research. The Company is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of Pharmaceutical Formulations. The Company's research and development facility is located in the state of Maharashtra, India and Gujarat, India, and its manufacturing facilities are located in the states of Maharashtra, Daman, Gujarat, Himachal Pradesh, and Sikkim.
OPERATIONS:
The Revenues for the year increased by 21.01% to INR 51344.423 Million. Profit before Tax (PBT) for the year amounted to INR 12182.498 Million as against a PBT of INR 8315.065 Million for the last year. Tax Expenses for the current year amounted to INR 2598.258 Million as against a tax of INR 1852.383 Million.
UNSECURED LOANS:
|
PARTICULAR |
31.03.2017 INR In Million |
31.03.2016 INR In Million |
|
Long-term
Borrowings |
|
|
|
Rupee term loans from banks |
76.850 |
76.850 |
|
Total |
76.850 |
76.850 |
INDEX OF CHARGE:
|
SNo |
SRN |
Charge Id |
Charge Holder Name |
Date of Creation |
Date of Modification |
Date of Satisfaction |
Amount |
Address |
|
1 |
B84988856 |
10449057 |
ICICI BANK LTD. |
19/09/2013 |
- |
- |
22160000.0 |
1st Floor, Ganesh Darshan Building, L. T. Road, Opposite Shri Sagar Hotel, Borivali (West), Mumbai-400092, Maharashtra, India |
|
2 |
B85015006 |
10449114 |
ICICI BANK LTD. |
19/09/2013 |
- |
- |
17850000.0 |
1st Floor, Ganesh Darshan Building, L. T. Road, Opposite Shri Sagar Hotel, Borivali (West), Mumbai-400092, Maharashtra, India |
|
3 |
B84990639 |
10449059 |
ICICI BANK LTD. |
19/09/2013 |
- |
- |
22160000.0 |
1st Floor, Ganesh Darshan Building, L. T. Road, Opposite Shri Sagar Hotel, Borivali (West), Mumbai-400092, Maharashtra, India |
|
4 |
B85072510 |
10449202 |
ICICI BANK LTD. |
19/09/2013 |
- |
- |
15460000.0 |
1st Floor, Ganesh Darshan Building, L. T. Road, Opposite Shri Sagar Hotel, Borivali (West), Mumbai-400092, Maharashtra, India |
|
5 |
B45539988 |
10029195 |
CITI BANK N.A. |
29/11/2006 |
05/03/2012 |
09/08/2012 |
600000000.0 |
Commercial Banking Group, Bandra Kurla Complex, Mumbai-400051, Maharashtra, India |
|
6 |
Y10326976 |
90224185 |
STATE BANK OF INDIA |
09/08/1990 |
- |
17/02/2006 |
6480000.0 |
Malad Branch, Mumbai-400021, Maharashtra, India |
|
7 |
Y10327286 |
90224495 |
STATE BANK OF INDIA |
22/03/1994 |
- |
17/02/2006 |
13020000.0 |
Malad Branch, Mumbai-400021, Maharashtra, India |
CONTINGENT
LIABILITIES:
(INR in million)
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
|
Other money for which company is contingently liable |
749.967 |
700.900 |
|
Total |
749.967 |
700.900 |
FIXED ASSETS:
Tangible Asset:
- Land
- Building
- Office equipment
- Plant and equipment
- Furniture and Fixture
- Computer
- Vehicles
Intangible Asset:
· Computer software
- Brands and trade marks
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 67.77 |
|
|
1 |
INR 89.96 |
|
Euro |
1 |
INR 78.86 |
INFORMATION DETAILS
|
Information
Gathered by : |
SUP |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
BHG |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
YES |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low risk
of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably on
secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the business
is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.